NCT06492759 2025-12-16High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast CancerEmory UniversityPhase 2 Not yet recruiting29 enrolled